In addition, sCRC tumours also featured the downregulation of genes involved in retinol metabolism or other processes such as fatty acid degradation, glycolysis, gluconeogenesis, and drug metabolism through cytochrome P450, as in the case of the ADH1B gene. Here, ADH1B is linked to neoplasm.